Atrial fibrillation (AF) and heart failure (HF): to treat the AF, be sure to treat the HF.
Prudente
Liza A
LA
University of Virginia, Charlottesville, VA, USA. lap4n@virginia.edu
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology*; D004359:Drug Therapy, Combination; D006333:Heart Failure / Q000150:complications* / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D009730:Nursing Assessment; D015995:Prevalence; D018570:Risk Assessment; D012307:Risk Factors; D012720:Severity of Illness Index; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control; D014481:United States / Q000453:epidemiology
D000319:Adrenergic beta-Antagonists; D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D000925:Anticoagulants